Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

11/08/2020 05:40

Aug 11 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.43               11.75            48.80    
                 (+5.8 pct)          (+3.4 pct)       (+4.0 pct)  
  Operating        967 mln             481 mln            1.60    
                (+101.0 pct)         (+86.5 pct)      (+58.3 pct) 
  Recurring          1.01              598 mln            1.50    
                 (+68.8 pct)         (+64.6 pct)      (+40.6 pct) 
  Net              721 mln             410 mln            1.10    
                 (+75.8 pct)         (+74.1 pct)      (+55.5 pct) 
  EPS             82.26 yen           46.77 yen       125.36 yen  
  Ann Div                             60.00 yen        60.00 yen  
  -Q2 div                             30.00 yen        30.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T